G
Gening Jiang
Researcher at Tongji University
Publications - 336
Citations - 5934
Gening Jiang is an academic researcher from Tongji University. The author has contributed to research in topics: Lung cancer & Pneumonectomy. The author has an hindex of 30, co-authored 301 publications receiving 3917 citations. Previous affiliations of Gening Jiang include Sun Yat-sen University.
Papers
More filters
Journal ArticleDOI
Development and Validation of a Nomogram for Predicting Survival in Patients With Resected Non–Small-Cell Lung Cancer
Wenhua Liang,Li Zhang,Gening Jiang,Qun Wang,Lunxu Liu,Deruo Liu,Zheng Wang,Zhihua Zhu,Qiuhua Deng,Xinguo Xiong,Wenlong Shao,Xiaoshun Shi,Jianxing He +12 more
TL;DR: A novel nomogram is established and validated that can provide individual prediction of OS for patients with resected NSCLC and may help clinicians in decision making and design of clinical studies.
Journal ArticleDOI
Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.
Wenhua Liang,Jiaxi He,Yaxing Shen,Jianfei Shen,Qihua He,Jianrong Zhang,Gening Jiang,Qun Wang,Lunxu Liu,Shugeng Gao,Deruo Liu,Zheng Wang,Zhihua Zhu,Calvin S.H. Ng,Chia-Chuan Liu,René Horsleben Petersen,Gaetano Rocco,Thomas A. D'Amico,Alessandro Brunelli,Haiquan Chen,Xiuyi Zhi,Bo Liu,Yixin Yang,Wensen Chen,Qian Zhou,Jianxing He +25 more
TL;DR: A greater number of ELNs is associated with more-accurate node staging and better long-term survival of resected NSCLC and is recommended as the cut point for evaluating the quality of LN examination or prognostic stratification postoperatively for patients with declared node-negative disease.
Journal ArticleDOI
Programmed cell death and its role in inflammation
TL;DR: An overview of the major types of cell death related to inflammation is provided and modified cell death pathways are likely to be a logical therapeutic target for inflammatory diseases.
Journal ArticleDOI
Prognostic effect of liver metastasis in lung cancer patients with distant metastasis.
Yijiu Ren,Chenyang Dai,Hui Zheng,F. Zhou,Yunlang She,Gening Jiang,Ke Fei,Ping Yang,Dong Xie,Chang Chen +9 more
TL;DR: Liver metastasis is found to be the worst prognostic factor for AD and SCLC patients with distant metastasis, and multiple survival outcomes are estimated by histology of primary tumor and sites of metastasis.
Journal ArticleDOI
Tumor Spread through Air Spaces Affects the Recurrence and Overall Survival in Patients with Lung Adenocarcinoma >2 to 3 cm
Chenyang Dai,Huikang Xie,Hang Su,Yunlang She,Erjia Zhu,Ziwen Fan,F. Zhou,Yijiu Ren,Dong Xie,Hui Zheng,Xiermaimaiti Kadeer,Donglai Chen,Liping Zhang,Gening Jiang,Chunyan Wu,Chang Chen +15 more
TL;DR: Preliminary evidence is provided that STAS could be considered as a factor in a staging system to predict prognosis more precisely, especially in ADCs larger than 2 to 3 cm.